Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2918640 | 1.00 | CYP3A4 (0.63) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL57683 | 1.00 | CYP3A4 (0.63) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL5173409 | 0.91 | TBXAS1 (0.58) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| Methacrylic Acid SCHEMBL10714804 | 0.91 | CYP3A4 (0.54) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| Oxirane SCHEMBL15646744 | 0.91 | CYP3A4 (0.54) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL9061442 | 0.89 | TP53 (0.59) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL15955486 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL15955485 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL5007835 | 0.88 | CYP3A4 (0.51) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL30752458 | 0.86 | RECQL (0.70) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3548890-B1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2024-03-27 | — | — | EP | claimed |
| EP-3548890-A1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | Gretz, Norbert (DE) | 2019-10-09 | — | — | EP | claimed |
| WO-2018100089-A1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2018-06-07 | — | — | WO | claimed |
| EP-2328938-B1 | RADICALLY FUNCTIONALIZED OLEFIN-BASED POLYMER WITH REDUCED MOLECULAR WEIGHT CHANGE AND METHOD | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-01 | — | — | EP | claimed |
| US-5961875-A | Antifreeze/coolant composition containing cinnamic acid | CCI CO., LTD. (JP) | 1999-10-05 | — | — | US | claimed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-3548890-B1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2024-03-27 | — | — | EP | disclosed |
| US-20230092002-A1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2023-03-23 | — | — | US | disclosed |
| CN-112745210-B | Method for preparing alpha, beta-unsaturated carboxylic acid compound | 中国科学院大连化学物理研究所 | 2022-02-15 | — | — | CN | disclosed |
| CN-108026028-B | Treatment of diabetes and metabolic syndrome with novel dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors | 威斯康星州医药大学股份有限公司 | 2021-11-09 | — | — | CN | disclosed |
| EP-2145042-B2 | TEXTILE SCENTING | HENKEL AG & CO KGAA (DE) | 2021-10-06 | — | — | EP | disclosed |
| CN-112745210-A | Method for preparing alpha, beta-unsaturated carboxylic acid compound | 中国科学院大连化学物理研究所 | 2021-05-04 | — | — | CN | disclosed |
| US-20190353565-A1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2019-11-21 | — | — | US | disclosed |
| US-5547967-A | HYPOTENSIVE AGENT, ANTIISCHEMIC AGENT | KALI-CHEMIE PHARMA GMBH (DE) | 1996-08-20 | — | — | US | disclosed |
| EP-0048433-B1 | NOVEL AMIDINE COMPOUNDS, PROCESS FOR PRODUCING SAME AND ANTI-COMPLEMENT AGENT COMPRISING THEM | TORII & CO., LTD. (JP) | 1986-05-28 | — | — | EP | disclosed |
| US-4532255-A | Amidine compounds and anticomplement agent comprising same | TORII & CO., LTD. (JP) | 1985-07-30 | — | — | US | disclosed |
| US-4454338-A | 6-AMIDINO-2-NATHTHYL-4-GUANIDINOBENZOATE | TORII & CO., LTD. (JP) | 1984-06-12 | — | — | US | disclosed |
| EP-0048433-A2 | Novel amidine compounds, process for producing same and anti-complement agent comprising them | TORII & CO., LTD. (JP) | 1982-03-31 | — | — | EP | disclosed |
| US-4166131-A | ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANTIARTHRITIC AGENT | HEXACHIMIE SOCIETE ANONYME (FR) | 1979-08-28 | — | — | US | disclosed |
| US-4010191-A | Acyl derivatives of substituted bis-arylalkylamino compounds | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-03-01 | — | — | US | disclosed |